Genome Engineering for Personalized Arthritis Therapeutics
Year: 2017
Type: review
Source: Trends in Molecular Medicine
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: green
Funders: Arthritis Foundation, Nancy Taylor Foundation for Chronic Diseases, Paul G. Allen Frontiers Group, National Institutes of Health, National Institute on Aging, National Institute on Drug Abuse, National Human Genome Research Institute, National Institute of General Medical Sciences, National Institute of Arthritis and Musculoskeletal and Skin Diseases
Awards: G1146952920, G1651706053, Spatially Controlled Gene Delivery of Morphogenetic Factors from Woven Scaffolds, Medical Scientist Training Program, Genome Editing of Stem Cells for Analysis of Osteoarthritis Causal Variants, Decoding and Reprogramming the Corticosteroid Transcriptional Regulatory Network, Engineering Morphogenetic Factors for Enhanced Genetic Reprogramming, G3255927981, G3338449564, Biomechanics and Inflammation in Osteoarthritis, G4066918929, G4177590129, G4808646772, G5045488169, Intrinsic Repair of the Knee Meniscus, G5857572858, G6008810260, Engineering Targeted Epigenetic Modifiers for Precise Control of Gene Regulation, Viscoelastic Properties of Normal and OA Chondrons, Scaffold-Mediated Gene Delivery for Engineering of Osteochondral Tissues, G7223610679, Mechanical and Osmotic Signaling in Chondrocytes, G7659916961, CRISPR/Cas9-Based Gene Editing for the Correction of Duchenne Muscular Dystrophy, A Platform Technology for High-Throughput Screening of Gene Regulatory Elements, Medical Scientist Training Program Training Grant
OpenAlex ID: W2751501426